Healthier Lives Across Generations: A Blueprint for Intergenerational Living

by James Fuccione | Oct 30, 2024 | Data and Reports, News and Updates

The organization Generations United released “Healthier Lives Across Generations: A Blueprint for Intergenerational Living,” which is focused on intentional intergenerational living, or communities open to people of all ages that have a deliberate focus on...

Healey-Driscoll Administration Announces $161 Million for Economic Development Projects that Include Senior Housing and COAs

by James Fuccione | Oct 28, 2024 | News and Updates

Governor Maura Healey, Lieutenant Governor Kim Driscoll, Economic Development Secretary Yvonne Hao and Housing and Livable Communities Secretary Ed Augustus announced more than $161 million for 313 grant awards to support local economic development projects in 171...

Residential Retrofit Program Seeking Public and Affordable Housing Operators to Improve Broadband Access

by James Fuccione | Oct 25, 2024 | News and Updates

Mass Broadband Institute (MBI) is seeking operators of public and affordable housing properties in Massachusetts to participate in the Residential Retrofit Program. Communities working to become more age- and dementia friendly can partner with local housing operators...

Healey-Driscoll Administration Announces Fare Free Regional Transit Across State

by James Fuccione | Oct 25, 2024 | News and Updates

The Healey-Driscoll Administration recently announced $30 million in grants to 13 Regional Transit Authorities (RTAs) in Massachusetts to provide year-round, fare free public transportation services. The funding was provided in the Fiscal Year 2025 budget signed by...

CDC Recommends Second Dose of 2024-2025 COVID-19 Vaccine for People 65 Years and Older and for People Who are Moderately or Severely Immunocompromised

by James Fuccione | Oct 25, 2024 | News and Updates

The Centers for Disease Control and Prevention (CDC) Director Mandy Cohen recently endorsed the CDC Advisory Committee on Immunization Practices’ (ACIP) recommendation for people 65 years and older and those who are moderately or severely immunocompromised to...